The global sleep apnea oral appliances market is projected to reach 0.7 billion by 2027, at a CAGR of 15.2%. Market growth is driven by the high adoption of innovative sleep apnea oral appliances, and wide availability of undiagnosed sleep apnea patients.
Sleep apnea oral appliances Market Dynamics
Globally, many countries are becoming increasingly conscious of the economic impact of untreated Sleep apnea. . Obstructive sleep apnea (OSA) is a dangerous disease that can severely damage the heart if left untreated. Long-term undiagnosed sleep apnea can also lead to several related diseases, such as cardiovascular disease or even congestive heart failure, type 2 diabetes, stroke, other sleep disturbances, and many other problems, including cognitive and memory impairments.
Growing awareness about the economic impact of untreated sleep apnea encourages stakeholders in the healthcare sector (key market players, government bodies, and physician groups) to stress the necessity of timely diagnosis and management of sleep apnea. These stakeholders take initiatives in the form of various campaigns to create awareness about the consequences of long-term undiagnosed sleep apnea.
Complex referral pathways and long waiting periods challenge the sleep apnea oral appliances market growth
The referral channel from primary care physicians (PCPs) to sleep specialists and then to Durable Medical Equipment (DME) divisions, home healthcare dealers, or dental practitioners often creates bottlenecks for the accurate diagnosis and follow-up treatment of OSA. Most patients do not have the patience for such lengthy referral processes and often give up before reaching a sleep specialist. This might also lead to delayed diagnosis. Other factors like shortage of dental professionals, lack of training and awareness regarding sleep apnea among dentists and primary care physicians, and a severe shortage of well-equipped sleep centers also act as deterrents to the effective diagnosis and management of sleep apnea.
Alternative therapies and medication a key restraining factor holding back growth of market
While positive airway pressure therapy is the first line of treatment for sleep apnea, patient compliance is a problem. As the conventional PAP therapy may be difficult to tolerate and compliance to these devices often declines, patients seek alternate options, such as expiratory positive airway pressure (EPAP), hypoglossal nerve stimulation, oral pressure therapy (OPT), and positional therapy. Whereas sleep apnea treatment also includes pharmacological modalities.
In 2021, mandibular advancement devices segment accounted for the largest share of the sleep apnea oral appliances market, by product
The global sleep apnea oral appliances market is segmented into mandibular advancement devices (MADs) and tongue-retaining devices (TRDs) based on product. Market growth for mandibular advancement device is largely driven by the popularity of MADs backed by the extensive research supporting their effectiveness as compared to TRDs.
In 2021, physician-prescribed/ customized oral appliances segment accounted for the largest share in the sleep apnea oral appliances market, by purchase type
The sleep apnea oral appliances market is segmented into physician-prescribed/ customized oral appliances and online OTC oral appliances by purchase type. The spinal cord stimulation segment accounted for the largest share owing to the increasing awareness of sleep apnea and rising patient preference for prescribed and customized oral appliances.
In 2021, home care settings/individuals segment accounted for the largest share in the sleep apnea oral appliances market, by end user
The sleep apnea oral appliances market is segmented into home care settings/individuals, hospitals, and dental clinics. In 2021, home care settings/individuals accounted for the largest share of the sleep apnea oral appliances market. This can be attributed to the rising number of innovative home sleep